BROKEN-SWEDEHEART-Optimized Pharmacological Treatment for Broken Heart (Takotsubo) Syndrome
Status:
Recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to document an optimized pharmacologic treatment for patients with
Takotsubo Syndrome. There is currently no published documentation in a large number of
patients. The study is a Randomized Registry Clinical Trial and in total 1000 patients
registered in SWEDEHEART will be included.